13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 37 holding rows worth $286,652,000.
- Accession
- 0001144204-16-102561
- Filer
- CIK 1633313
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 41 entries on the cover page, a total value of $286,652,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $286,652,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,404,055 | $30,047,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,424,104 | $28,934,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 277,272 | $22,869,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,155,000 | $22,546,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 175,400 | $16,112,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 405,320 | $16,030,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 3,125,198 | $15,876,000 | thousands by filing date | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 1,416,257 | $15,621,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 270,665 | $12,445,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 175,000 | $11,179,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 2,400,868 | $9,988,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 166,700 | $8,910,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 537,477 | $7,589,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 854,579 | $7,144,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 150,000 | $6,605,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 1,145,779 | $6,164,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 4,069,072 | $5,168,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 925,000 | $4,533,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 211,672 | $4,426,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 1,337,869 | $4,147,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HOLDINGS | 71426V108 | COM | 3,889,900 | $4,084,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 730,514 | $3,945,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 175,000 | $3,619,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 208,086 | $3,300,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,050,457 | $2,626,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 228,697 | $2,115,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 307,500 | $2,006,000 | thousands by filing date | call |
| VERICEL CORP | 92346J108 | COM | 275,000 | $1,612,000 | thousands by filing date | |
| NANTKWEST INC | 63016Q102 | COM | 194,912 | $1,602,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 233,334 | $1,601,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767E102 | COM | 306,800 | $1,135,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 74,800 | $1,085,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 25,000 | $688,000 | thousands by filing date | |
| SPDR SERIES TRUST | 78464A950 | PUT | 750,000 | $670,000 | thousands by filing date | put |
| CATALYST | 14888D109 | COM | 71,500 | $120,000 | thousands by filing date | |
| INTREXON CORP | 46122T102 | COM | 200,000 | $60,000 | thousands by filing date | call |
| ISHARES TR | 464287955 | PUT | 250,000 | $51,000 | thousands by filing date | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-16-102561 | this filing | 2016-05-16 | acceptance time not in the bulk data set |